Drug Topics

JULY 18, 2023

Over the last 5 years, both PBMs and drug manufacturers have implemented restrictions that raise patients’ cost burden for specialty medications.

Pharmaceutical Companies 186

Pharmaceutical Companies Pharmaceutical Companies 186

Pharmacy Times

JULY 18, 2023

Study suggests supplemental oxygen may improve cognitive functions that are vital in motor learning, which can be important for people with neurological conditions or trauma.

123

123

Drug Topics

JULY 18, 2023

The Drug Supply Chain Security Act has been a decade in the making. Pharmacists must be prepared to comply by November 2023.

187

187

Pharmacy Times

JULY 18, 2023

Though the overall significance of the results were low, vitamin D was found to be especially useful in lowering the prevalence of myocardial infarction in older adults.

123

123

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Drug Topics

JULY 18, 2023

Filling prescriptions is no longer a sufficient source of revenue for community pharmacy.

Community Pharmacies 187

Community Pharmacies 187

Pharmacy Times

JULY 18, 2023

Therapeutic drug monitoring is a growing and vital area for pharmacists to become involved in to increase patient success with inflammatory bowel disease remission.

123

123

Pharmacy Times

JULY 18, 2023

With the end of the national public health emergency for COVID-19 in May 2023, what can be expected as we look ahead to the 2023-2024 influenza season and beyond?

Vaccines 123

Vaccines 123

STAT

JULY 18, 2023

In Phoenix, where daytime temperatures are topping 110 degrees Fahrenheit for the third straight week, emergency room doctors think of extreme heat as the public health emergency it has proved itself to be: In 2022, Arizona’s Maricopa County reported a 25% increase in heat-related mortality from the previous year. “Heat is just something we know we need to be really worried about,” said Geoff Comp, an emergency medicine physician at Valleywise Health Medical Center.

Hospitals 98

Hospitals 98

Pharmacy Times

JULY 18, 2023

This months OTC products include brain fuel, SPF 50 mineral sunscreen, women's ensemble, and kids SPF 50 gentle lotion sunscreen.

119

119

Fierce Healthcare

JULY 18, 2023

Teladoc is ramping up its investment in AI to infuse innovation into its telehealth solution for hospitals. | Teladoc is ramping up its investment in AI to infuse innovation into its telehealth solution for hospitals. The largest telehealth company is tapping into its two-year partnership with tech giant Microsoft to integrate AI and speech recognition tech into its Solo virtual care platform.

Hospitals 98

Hospitals 98

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

JULY 18, 2023

Participants were able to stop treatment after achieving amyloid plaque clearance and experience lasting results.

123

123

Fierce Healthcare

JULY 18, 2023

Emergency visits and inpatient admissions for conditions related or adjacent to extreme heat events are costing the U.S. | A recent extrapolation of Virginia weather trends and care utilization data suggests that about 234,000 excess emergency department visits and 56,000 hospital admissions occur nationwide due to heat event days.

Hospitals 98

Hospitals 98

The Checkup by Singlecare

JULY 18, 2023

If you’ve been diagnosed with high blood pressure , chances are that you were advised to follow the DASH eating plan. The DASH diet emphasizes eating lots of fruits, veggies, and whole grains while limiting salt, saturated fats, and sweets. The DASH diet is a highly effective meal plan with multiple health benefits for people with hypertension and other related conditions, but starting the plan can feel overwhelming at first.

Hospitals 98

Hospitals 98

Fierce Healthcare

JULY 18, 2023

The Centers for Medicare & Medicaid Services (CMS) could remove PET scan restrictions to better determine whether patients qualify for new drugs and to shine light on whether a drug is slowing | CMS could remove PET scan restrictions that limit just one brain scan per clinical trial to better determine whether new Alzheimer's drugs are slowing cognitive decline.

98

98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

STAT

JULY 18, 2023

Pharma giant Pfizer is turning to venture firm Flagship for new drug development, signing a deal worth up to $7 billion to mine new medicines from the latter’s portfolio companies. Flagship and Pfizer announced Tuesday that they will each put $50 million into developing up to 10 drug candidates. Pfizer will have first rights to acquire each for up to $700 million, plus royalties.

98

98

Hospital Pharmacy Europe

JULY 18, 2023

Eblasakimab is the first biologic treatment for moderate to severe atopic dermatitis to show a competitive efficacy profile when given as a once-monthly dose, according to data released by the manufacturer, Aslan pharmaceuticals. The novel monoclonal antibody targets the interleukin-13 (IL-13) receptor subunit of the Type 2 receptor, that is a key pathway in several allergic inflammatory diseases, including atopic dermatitis.

Hospitals 98

Hospitals 98

Drug Store News

JULY 18, 2023

The program allows small business owners and entrepreneurs to apply for the opportunity to pitch their products and possibly have them sold on Walmart or Sam's Club shelves or online.

98

98

STAT

JULY 18, 2023

Medicaid is an essential source of maternal and postpartum care for low-income Americans, covering 42% of births in the U.S. People who give birth receive maternity care until at least two months after delivery, or longer depending on state or local policies. But many immigrants don’t have access to this coverage, making them more vulnerable to maternal health problems, as highlighted by a new study of nearly 73,000 postpartum people across 19 states and New York City between 2012 and 201

98

98

Hospital Pharmacy Europe

JULY 18, 2023

Donanemab has been found to slow the progression of early symptomatic Alzheimer’s disease after 76 weeks of treatment, according to the findings of a phase 3 randomised trial. The monoclonal antibody donanemab, which targets the insoluble, modified, N-terminal truncated form of β-amyloid present only in brain amyloid plaques, was given to patients with early symptomatic Alzheimer disease with amyloid and tau pathology.

Hospitals 98

Hospitals 98

STAT

JULY 18, 2023

This article is adapted from the 2023 edition of STAT’s annual report, “Ranking biotech’s top venture capital firms.” A RCH Venture Partners, the long-running investment firm that in recent years has dedicated itself to backing biotechs with grandiose plans , also delivered some of the best returns on outside investors’ money, according to the 2023 edition of STAT’s annual ranking of biotech venture capital performance.

98

98

Drug Store News

JULY 18, 2023

Focus has shifted from categories like immunity protection and foundational health toward products that enhance fitness and active lifestyles, per The Vitamin Shoppe's report.

Immunization 98

Immunization 98

Fierce Healthcare

JULY 18, 2023

Fewer target Provider Relief Fund (PRF) payments sent to hospitals during the COVID-19 pandemic’s opening year reached hospitals serving patient populations with more Hispanic/Latino Americans, acc | The government watchdog found that hospitals serving heavier concentrations of Hispanic/Latino Americans were tied to lower Provider Relief Fund payments in 2020.

Hospitals 98

Hospitals 98

Hospital Pharmacy Europe

JULY 18, 2023

Use of a direct oral penicillin challenge in patients with a low-risk of penicillin allergy has been shown to be non-inferior to the standard-of-care skin testing in the recent PALACE randomised trial. Removing the label of being allergic to penicillin involves intra-dermal skin testing followed by an oral penicillin challenge. Now, an international research group has shown that a direct oral penicillin challenge in those with a low-risk penicillin allergy is equally as safe as the current stand

Immunization 98

Immunization Labelling Hospitals 98

STAT

JULY 18, 2023

A new $50 million nonprofit initiative aims to independently evaluate health technologies’ impact on costs and quality, an attempt to help patients, payers, and providers sort over-hyped products from ones that actually move the needle. The Peterson Center on Healthcare, a nonprofit supporting programs that raise care quality and drive down costs, announced the new Peterson Health Technology Institute Tuesday.

Insurance 98

Insurance 98

Fierce Pharma

JULY 18, 2023

On the heels of wrapping up a $15 billion share buyback program, Novartis has unveiled another stock repurchase plan of the same size. | On the heels of wrapping up a $15 billion share buyback, Novartis has unveiled another stock repurchase plan of the same size. This comes even as the company's top-selling drug, Entresto, faces patent challenges.

98

98

Drug Topics

JULY 18, 2023

Device adoption among minority patients with type 1 and type 2 diabetes remains low due to socioeconomic disparities.

98

98

Fierce Pharma

JULY 18, 2023

In the world of drug packaging, a vial is a vial, the product the product, and never the twain shall meet. When those standards start to slip, recalls are sure to follow. | In tandem with Taiwan’s Food and Drug Administration, GSK this week initiated a recall of two batches of its severe asthma injection Nucala after glass fragments were found in a vial of the drug.

Packaging 97

Packaging 97

STAT

JULY 18, 2023

I’ve heard “WebMD said it could be cancer” countless times in my 15 years working as an emergency medicine physician. I get it: When someone is feeling unwell or hoping a worrying symptom will go away, it makes sense for them to turn to easily accessible resources. As people become increasingly familiar with artificial intelligence platforms like ChatGPT, it’s only a matter of time before patients turn to these tools in search of a diagnosis or second opinion.

Insurance 97

Insurance Hospitals 97

Fierce Pharma

JULY 18, 2023

Johnson & Johnson has hopped on the litigation bandwagon, becoming the fourth large drugmaker to sue the U.S. government over drug price negotiations in the Inflation Reduction Act (IRA). | Johnson & Johnson has hopped on the litigation bandwagon, becoming the fourth Big Pharma company to sue the U.S. government over drug price negotiations in the Inflation Reduction Act.

97

97

STAT

JULY 18, 2023

Most everything is looking up for Orexo, the company reported on its second quarter earnings call on Tuesday. That is, everything but its digital therapies pipeline. The Swedish pharmaceutical company, which makes almost all of its money from U.S. sales of its drug for opioid dependence, notched a number of important victories in the quarter: It successfully defended its patents in a case against Sun Pharmaceuticals, it resolved a packaging issue that was holding up the approval of its long-acti

Packaging 97

Packaging Pharmaceutical Companies Pharmaceutical Companies 97

European Pharmaceutical Review

JULY 18, 2023

A market report by Meticulous Research has reported that rising pressure to reduce overall process costs has meant many pharma and biotech manufacturers are focusing on streamlining their processes by using quality management systems. According to the research, the pharmaceutical quality management systems market is projected to reach $3.97 billion by 2030.

Documentation 96

Documentation Pharmaceutical Companies Pharmaceutical Companies 96

STAT

JULY 18, 2023

WASHINGTON — Senate health committee Chair Bernie Sanders (I-Vt.) added three drug shortage measures to a pandemic-preparedness bill that his committee will consider Thursday. Only one of them, however, would grant the Food and Drug Administration new authorities to tackle the issue. Congress is under pressure to stem drug shortages amid reports of doctors rationing chemotherapies and other essential medicines.

Chemotherapy 97

Chemotherapy FDA 97

Fierce Pharma

JULY 18, 2023

After bagging a highly anticipated FDA nod Monday, Sanofi and AstraZeneca’s respiratory syncytial virus (RSV) antibody now has a date on a committee's calendar to determine its place in U.S. | After the FDA approved Sanofi and AstraZeneca's RSV antibody for infants, the next step in the launch is a discussion and potential recommendation from the CDC's vaccine advisory committee.

Vaccines 96

Vaccines FDA 96

STAT

JULY 18, 2023

Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET. Now that biosimilar versions of Humira are starting to arrive, what happens next? Will this finally prove the case that biosimilars can deliver on big health care savings? What key signals will indicate how biosimilars might be prescribed, or paid for?

95

95